Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Getsios

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2009
Underestimation of invasive meningococcal disease case fatality ratesPascal Crépey, Denis Getsios
Expert Opinion on Pharmacotherapy|February 28, 2002
Pharmacoeconomic evidence and considerations for triptan treatment of migraineJ Jaime Caro, Denis Getsios
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 25, 2007
Regarding probabilistic analysis and computationally expensive models: necessary and required?J Jaime Caro, Denis Getsios, Jörgen Möller
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 10, 2010
Discrete event simulation: the preferred technique for health economic evaluations?Jaime J Caro, Jörgen Möller, Denis Getsios
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 15, 2006
Managing meningococcal disease in the United States: Hospital case characteristics and costs by ageJudith A O'Brien, J Jaime Caro, Denis Getsios
Pharmacoeconomics|February 23, 2016
Systematic Review of Model-Based Economic Evaluations of Treatments for Alzheimer's DiseaseLuis Hernandez, Asli Ozen, Rodrigo DosSantos, et al.
Pharmacoeconomics|December 1, 2007
NICE cost-effectiveness appraisal of cholinesterase inhibitors: was the right question posed? Were the best tools used?Denis Getsios, Kristen Migliaccio-Walle, Jaime J Caro
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Economic assessments of low molecular weight heparin in venous thromboembolismAlexandra Ward, Denis Getsios, Judith O'Brien, et al.
Pharmacoeconomics|October 21, 2005
Pharmacological management of overactive bladder : a systematic and critical review of published economic evaluationsDenis Getsios, Wissam El-Hadi, Ingrid Caro, et al.
Pharmacoeconomics|July 27, 2002
Cost effectiveness of tinzaparin sodium versus unfractionated heparin in the treatment of proximal deep vein thrombosisJ Jaime Caro, Denis Getsios, Ingrid Caro, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2009
Underestimation of invasive meningococcal disease case fatality ratesPascal Crépey, Denis Getsios
Expert Opinion on Pharmacotherapy|February 28, 2002
Pharmacoeconomic evidence and considerations for triptan treatment of migraineJ Jaime Caro, Denis Getsios
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 25, 2007
Regarding probabilistic analysis and computationally expensive models: necessary and required?J Jaime Caro, Denis Getsios, Jörgen Möller
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 10, 2010
Discrete event simulation: the preferred technique for health economic evaluations?Jaime J Caro, Jörgen Möller, Denis Getsios
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 15, 2006
Managing meningococcal disease in the United States: Hospital case characteristics and costs by ageJudith A O'Brien, J Jaime Caro, Denis Getsios
Pharmacoeconomics|February 23, 2016
Systematic Review of Model-Based Economic Evaluations of Treatments for Alzheimer's DiseaseLuis Hernandez, Asli Ozen, Rodrigo DosSantos, et al.
Pharmacoeconomics|December 1, 2007
NICE cost-effectiveness appraisal of cholinesterase inhibitors: was the right question posed? Were the best tools used?Denis Getsios, Kristen Migliaccio-Walle, Jaime J Caro
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Economic assessments of low molecular weight heparin in venous thromboembolismAlexandra Ward, Denis Getsios, Judith O'Brien, et al.
Pharmacoeconomics|October 21, 2005
Pharmacological management of overactive bladder : a systematic and critical review of published economic evaluationsDenis Getsios, Wissam El-Hadi, Ingrid Caro, et al.
Pharmacoeconomics|July 27, 2002
Cost effectiveness of tinzaparin sodium versus unfractionated heparin in the treatment of proximal deep vein thrombosisJ Jaime Caro, Denis Getsios, Ingrid Caro, et al.
Pageof 4